Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Tedizolid Phosphate). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
Indications & Uses
Absi is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Tedizolid Phosphate is recommended in patients with 18 years of age or older. Tedizolid should be administered 200 mg once daily for six (6) days orally (with or without food). If patients miss a dose, they should take it as soon as possible at anytime up to 8 hours prior to their next scheduled dose. If less than 8 hours remain before the next dose, wait until their next scheduled dose.Use in Children & Adolescents: Safety and effectiveness in paediatric patients below the age of 18 have not been established. No overall differences in pharmacokinetics were observed between elderly subjects and youngersubjects.
Side Effects
The most common side effects in patients treated with Tezolin are nausea, headache, diarrhea, vomiting and dizziness. The following selected adverse reactions may be reported in Tezolin treated patients: anemia, palpitations, tachycardia, blurred vision, visual impairment, infusion-related reactions, drug hypersensitivity, insomnia, pruritus, urticaria, dérmatitis and hypertension etc.
Cautions & Contraindications
Warnings & Precautions
Alternative therapies should be considered when treating patients with neutropenia and acute bacterial skin and skin structure infection, Clostridium difficile-associated diarrhea and the risk of the development of drug-resistant bacteria.Pharmaceutical precautions: Administer Tezolin infusion as an intravenous infusion only. The intravenous bag containing the reconstituted and diluted intravenous solution should be inspected visually for particulate matter prior to administration. After reconstitution and dilution, it is to be administered via intravenous infusion using a total time of 1 hour. The total time from reconstitution to administration should not exceed 24 hours at room temperature or under refrigeration at 2°C to 8°C.
Contraindications
Tedizolid Phosphate is contraindicated in patients who have known hypersensitivity to Tedizolid Phosphate orany other components of Tedizolid Phosphate.